1. Van Nueten JM, Janssen PAJ, Van Beek J, Xhonneaux R, Verbeuren TJ, Vanhoutte PM (1981) Vascular effects of ketanserin (R 41 468), a novel antagonist of 5-HT2 serotonergic receptors. J Pharm Exp Ther 218: 217?230
2. Leysen JE, Awouters F, Kennis L, Laduron PM, Vandenberk J, Janssen PAJ (1981) Receptor binding profile of R 41 468, a novel antagonist at 5-HT2 receptors. Life Sci 28: 1015?1022
3. De Cree, Verhaegen H, Symoens J (1981) Acute blood pressure lowering effect of ketanserin. Lancet i: 1161?1162
4. Weiner CP, Socol ML, Vaisrub N (1984) Control of pre-eclamptic hypertension by ketanserin, a new serotonin receptor antagonist. Am J Obstet Gynecol 149: 496?500
5. Van der Starre PJA, Scheijgrond HW, Renemann RS, Bach Kolling J (1983) The use of ketanserin, a 5-hydroxytryptamine receptor antagonist, for treatment of postoperative hypertension following coronary artery bypass surgery. Anesth Analg 62: 63?69